Topics

Pediatric-type diffuse high-grade gliomas | Treatment | Case reports | Lorlatinib

Home > Publications > Topics > Pediatric-type diffuse high-grade gliomas > Treatment > Case reports > Lorlatinib

Wilson D, Jayappa S, Parker L, Ocal E, Tanaka T, Gokden M, Bielamowicz K.
Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance.
Int J Mol Sci. 2025 Oct 10;26(20):9864. doi: 10.3390/ijms26209864. PMID: 41155159. Case report. ˍ